Just a 2 day manipulation by those who had news of the deal beforehand and ran it up yesterday, and rammed it back own this morning to shake out some shares.
GILD has been linked with 3 or 4 other buyout names, although INCY has been mentioned in another article as well.
I have decided to Ride the Wave on INCY, but it sure has sunk low since hitting $120 last week. And I see Viselinger is back again... that shortie.
Hope you are right though I will remain balanced in my investment until I see some real performance in the stock, and research and FDA results.
CLDX had a secondary when the price was about $5, then the stock quickly ran up to $38 within 6 months. I sold way to soon, and lost out on the big run. I won't be selling EXEL anytime soon.